138 related articles for article (PubMed ID: 9453568)
1. Endogenously occurring beta-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease.
Matsubara K; Gonda T; Sawada H; Uezono T; Kobayashi Y; Kawamura T; Ohtaki K; Kimura K; Akaike A
J Neurochem; 1998 Feb; 70(2):727-35. PubMed ID: 9453568
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic activation of azaheterocyclics induced dopaminergic toxicity: possible candidate neurotoxins underlying idiopathic Parkinson's disease].
Matsubara K
Nihon Hoigaku Zasshi; 1998 Oct; 52(5):301-5. PubMed ID: 10077975
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral injection of low amounts of norharman induces moderate Parkinsonism-like behavioral symptoms in rat.
Esmaeili MH; Movahedi M; Faraji A; Haghdoost-Yazdi H
Neurotoxicol Teratol; 2012; 34(5):489-94. PubMed ID: 22789434
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
[TBL] [Abstract][Full Text] [Related]
6. Potential bioactivated neurotoxicants, N-methylated beta-carbolinium ions, are present in human brain.
Matsubara K; Collins MA; Akane A; Ikebuchi J; Neafsey EJ; Kagawa M; Shiono H
Brain Res; 1993 Apr; 610(1):90-6. PubMed ID: 8518935
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
8. Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
Collins MA; Neafsey EJ; Cheng BY; Hurley-Gius K; Ung-Chhun NA; Pronger DA; Christensen MA; Hurley-Gius D
Adv Neurol; 1987; 45():179-82. PubMed ID: 3493625
[No Abstract] [Full Text] [Related]
9. Effect of 2-guanidinoethanol on levels of monoamines and their metabolites in the rat brain.
Yokoi I; Itoh T; Yufu K; Akiyama K; Satoh M; Murakami S; Kabuto H; Mori A
Neurochem Res; 1991 Oct; 16(10):1155-9. PubMed ID: 1724554
[TBL] [Abstract][Full Text] [Related]
10. Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging.
Pasinetti GM; Osterburg HH; Kelly AB; Kohama S; Morgan DG; Reinhard JF; Stellwagen RH; Finch CE
Brain Res Mol Brain Res; 1992 Mar; 13(1-2):63-73. PubMed ID: 1374506
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK
Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
Date I; Felten DL; Felten SY
Brain Res; 1990 Jun; 519(1-2):266-76. PubMed ID: 1975765
[TBL] [Abstract][Full Text] [Related]
13. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
[TBL] [Abstract][Full Text] [Related]
14. Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism?
Collins MA; Neafsey EJ
Neurosci Lett; 1985 Apr; 55(2):179-84. PubMed ID: 2582318
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
[TBL] [Abstract][Full Text] [Related]
17. 9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease.
Wernicke C; Hellmann J; Zieba B; Kuter K; Ossowska K; Frenzel M; Dencher NA; Rommelspacher H
Pharmacol Rep; 2010; 62(1):35-53. PubMed ID: 20360614
[TBL] [Abstract][Full Text] [Related]
18. Long term exposure to norharman exacerbates 6-hydroxydopamine-induced parkinsonism: possible involvement of L-type Ca2+ channels.
Haghdoost-Yazdi H; Hosseini SS; Faraji A; Nahid D; Jahanihashemi H
Behav Brain Res; 2010 Dec; 215(1):136-40. PubMed ID: 20638417
[TBL] [Abstract][Full Text] [Related]
19. Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.
Ostergren A; Fredriksson A; Brittebo EB
J Neural Transm (Vienna); 2006 Mar; 113(3):313-29. PubMed ID: 16075188
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease-like syndrome in rats induced by 2,9-dimethyl-beta-carbolinium ion, a beta-carboline occurring in the human brain.
Lorenc-Koci E; Rommelspacher H; Schulze G; Wernicke C; Kuter K; Smiałowska M; Wierońska J; Zieba B; Ossowska K
Behav Pharmacol; 2006 Sep; 17(5-6):463-73. PubMed ID: 16940767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
